Catalyst Wire Dossier Catalyst Wire Dossier

Fursultiamine

fursultiamine
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Fursultiamine, covering 2019-03-13 to 2019-03-13. Get the full timeline:

Most recent: Clinical Trial Update: Fursultiamine in Esophageal Squamous Cell Carcinoma Patients Who Receive Concurrent Chemoradiotherapy [Phase 2]

See pricing